Opposing Effects of Sodium Salicylate and Haematopoietic Cytokines IL-3, IL-5 and GM-CSF on Mitogen-Activated Protein Kinases and Apoptosis of EOL-1 Cells
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Immunological Investigations
- Vol. 28 (5-6) , 365-379
- https://doi.org/10.3109/08820139909062270
Abstract
Haematopoietic cytokines such as IL-3, IL-5 and GM-CSF not only activate eosinophils but also prolong their life span by inhibiting their apoptotic cell death. We have studied the effects of IL-3, IL-5 and GM-CSF on apoptosis and mitogen-activated protein kinases (MAPKs) in a human eosinophilic leukaemic cell line (EoL-1). Results demonstrated that all three cytokines could trigger the receptor-mediated activation of extracellular signal-regulated kinase (ERK) within one hour but not p38 MAPK activity in EoL-1 cells. In contrast, sodium salicylate (NaSal), a nonsteroidal anti-inflammatory drug (NSAID), could activate p38 MAPK but not ERK within one hour. Both cytokines and specific p38 MAPK inhibitor SB 203580 could partly block the NaSal-induced apoptosis in EoL-1 cells. A specific MAPK/ERK kinase (MEK) inhibitor, PD 098059, could induce apoptosis and eliminate the protective effect of IL-3, IL-5 and GM-CSF against NaSal-induced apoptosis in EoL-1 cells. Taken together, cytokines IL-3, IL-5 and GM-CSF could prolong EoL-1 cells survival through the transient activation of ERK. On the other hand, activation of p38 MAPK in EoL-1 cells by NaSal could lead to apoptosis. Activation of p38 MAPK and the resulting induction of apoptosis in EoL-1 cells may be important to explain the anti-inflammatory action of NSAID in allergic inflammation.Keywords
This publication has 38 references indexed in Scilit:
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- Lyn, Jak2, and Raf-1 Kinases Are Critical for the Antiapoptotic Effect of Interleukin 5, whereas only Raf-1 Kinase Is Essential for Eosinophil Activation and DegranulationThe Journal of Experimental Medicine, 1998
- Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammationNature, 1997
- Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5Journal of Allergy and Clinical Immunology, 1996
- Fibroblast Growth Factor-2 Suppression of Tumor Necrosis Factor α-Mediated Apoptosis Requires Ras and the Activation of Mitogen-activated Protein KinaseJournal of Biological Chemistry, 1996
- Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?Immunology Today, 1995
- Eosinophils 1992Immunology Today, 1992
- GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cellsImmunology Today, 1992
- ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGFCell, 1991
- The Immunobiology of EosinophilsNew England Journal of Medicine, 1991